Astraea

AI Operating System for Clinical Development

·B2B SaaS·YC Spring 2026·tracked since Sep 25, 2026
WatchVisit site ↗
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders

About Astraea

Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.

Discover more startups

Browse the board →